Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
Published on Tue 25 Feb 2025 8:26:27 UTC
WILMINGTON, N.C., Feb. 25, 2025 /PRNewswire/ -- Frontier Scientific Solutions, a temperature-controlled storage and transportation company exclusively serving the life sciences industry, today announced the appointment of Kevin Nash as President of European Operations. Based in Shannon, Ireland, Nash will oversee the company's European expansion, strengthening transportation networks, optimizing supply chain efficiencies, and supporting the growing demand for specialized life sciences logistics solutions across the region.
Published on Tue 25 Feb 2025 8:26:19 UTC
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from the ongoing investigator-initiated trial (IIT) of YOLT-203 in patients with primary hyperoxaluria type 1 (PH1) (ClinicalTrials.gov ID: NCT06511349), with data demonstrating excellent safety and pharmacodynamics profiles and the potential of YOLT-203 to effectively normalize urinary oxalate levels in PH1 patients. YOLT-203 is the first in vivo gene-editing therapy to show positive clinical data for PH1.
Published on Tue 25 Feb 2025 8:24:36 UTC
STOCKHOLM, Feb. 25, 2025 /PRNewswire/ --
Published on Tue 25 Feb 2025 8:24:32 UTC
LUND, Sweden, Feb. 25, 2025 /PRNewswire/ --
Published on Tue 25 Feb 2025 8:24:19 UTC
ZEIST, Netherlands, Feb. 25, 2025 /PRNewswire/ -- Julius Clinical, a science-driven globalCRO specializing in Neurological, Cardio-Metabolic, Renal and Rare Diseases, is pleased to announce the establishment of Julius Clinical Poland, a new operational hub in Krakow. This expansion reinforces Julius Clinical's position as a global leader in CNS and Cardio-Metabolic research while enhancing its pan-European capabilities in clinical trials.
Published on Tue 25 Feb 2025 8:19:57 UTC
OSLO, Norway, Feb. 25, 2025 /PRNewswire/ --HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the fourth quarter 2024.
Published on Tue 25 Feb 2025 6:20:56 UTC
, , 25 2025 . /PRNewswire/ -- Vantage Foundation (National Burn Hospital Le Huu Trac) - , - , .
Published on Tue 25 Feb 2025 5:53:31 UTC
ST. LOUIS, Feb. 24, 2025 /PRNewswire/ --Healthcare amenities company HHP(Health Hospitality Partners) has announced an additional C-Suite role and several promotions reflecting the positive trajectory of the business. Key appointments include Colby Heiman as Chief Operating Officer and Cory Sullivan as the company's first Chief Revenue Officer.
Published on Tue 25 Feb 2025 5:53:29 UTC
HANOI, Vietnam, 24 fvrier 2025 /PRNewswire/ --La Fondation Vantage est fire d'annoncer son partenariat avec l'Hpital national des grands brls Le Huu Trac Hanoi, un tablissement mdical de premier plan spcialis dans le traitement des brlures et la rducation, afin d'apporter son soutien et une aide financire aux patients de tous ges qui suivent un traitement pour des brlures graves.
Published on Tue 25 Feb 2025 5:53:20 UTC
-TFS HealthScience anuncia una transicin de liderazgo: Katarina Ageborg nombrada presidenta del consejo de administracin y Markus Granlund nombrado consejero delegado interino
Published on Tue 25 Feb 2025 5:53:17 UTC
Berkshire Biomedical Today Launched Its First Public Investment Campaign to Support the Advancement of Its Revolutionary COPA Technology
Published on Tue 25 Feb 2025 5:53:16 UTC
CLEARWATER, Fla., Feb. 24, 2025 /PRNewswire/ -- When medical school students across the country are matched next month with post-graduate residency programs, up to 172 may end up in West Central Florida, thanks to continued growth in BayCare's graduate medical education (GME) programs, including its first ever Emergency Medicine residency program.
Published on Tue 25 Feb 2025 5:53:14 UTC
HANOI, Vietnam, 24. Februar 2025 /PRNewswire/ -- DieVantage Foundation gibt mit Stolz ihre Partnerschaft mit dem National Burn Hospital LeHuu Trac in Hanoi bekannt, einer fhrenden medizinischen Einrichtung, die sich auf die Behandlung von Verbrennungen und die folgende Rehabilitation spezialisiert hat, um Patientinnen und Patienten aller Altersgruppen, die sich einer Behandlung fr schwere Verbrennungen unterziehen, Untersttzung und finanzielle Hilfe zu bieten.
Published on Tue 25 Feb 2025 5:53:07 UTC
Fourth Quarter Highlights:
Published on Tue 25 Feb 2025 5:53:05 UTC
SAN RAFAEL, Calif., Feb. 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has appointed Timothy P. Walbert, former chairman, president and chief executive officer of Horizon Therapeutics, to the company's Board of Directors, effective Feb. 24, 2025.
Published on Tue 25 Feb 2025 5:53:03 UTC
IRVINE, Calif., Feb. 24, 2025 /PRNewswire/ -- American HealthcareREIT, Inc. (NYSE: AHR), announced today that President and Chief Executive Officer, Danny Prosky, Chief Financial Officer, Brian S. Peay, Chief Operating Officer, Gabe M. Willhite, and VP of Investor Relations & Finance, Alan Peterson, will participate in a roundtable discussion at the Citi 2025 Global Property CEO Conference on Monday, March 3, 2025, from 3:35 to 4:10 p.m. Eastern Time. A live webcast of the presentation will be available at the following link. A replay will be available for one year utilizing the same link following the completion of the conference on March 4, 2025.
Published on Tue 25 Feb 2025 5:53:01 UTC
ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members.
Published on Tue 25 Feb 2025 5:52:57 UTC
New appointees reinforce the Company's momentum in building a leading oncology therapeutics company
Published on Tue 25 Feb 2025 5:52:52 UTC
SAN FRANCISCO, Feb. 24, 2025 /PRNewswire/ --Rainfall Health, a leader in AI-driven healthcare solutions, is revolutionizing how health systems, from major institutions to rural health centers, achieve compliance with the Centers for Medicare & Medicaid Services (CMS) mandated TEAM model. By integrating cutting-edge artificial intelligence, Rainfall Health is making it seamless for healthcare organizations to drive better patient outcomes while maximizing reimbursement.
Published on Tue 25 Feb 2025 5:52:50 UTC
Two leading-edge, procedures: EmSculpt Neo to strengthen muscles and burn fat and EMSELLA to reduce incontinence unveiled during March 5 Grand Opening
Published on Tue 25 Feb 2025 5:52:48 UTC
DETROIT, Feb. 24, 2025 /PRNewswire/ -- Build Senior Living , a leader in developing and managing high-quality senior living communities, is calling for urgent regulatory reforms to improve workforce stability, protect vulnerable seniors, and ensure the highest standard of care in assisted living communities nationwide.
Published on Tue 25 Feb 2025 5:52:46 UTC
The HPV16+ HNSCC market is experiencing robust growth, driven by increasing awareness of HPV-related cancers and the rising incidence of oropharyngeal cancers. The development of immunotherapies and targeted treatments, such as immune checkpoint inhibitors, is fueling market expansion. Additionally, advancements in diagnostic techniques and personalized treatment options are improving patient outcomes, contributing to the market's upward trajectory.
Published on Tue 25 Feb 2025 5:52:41 UTC
LOS ANGELES, Feb. 24, 2025 /PRNewswire/ --California has introduced a new initiative to advance critical research for ALS and related neurodegenerative diseases like Parkinson's, Alzeheimer's, and frontotemporal dementia.
Published on Tue 25 Feb 2025 5:51:43 UTC
Exciting expansion into Africa
Published on Tue 25 Feb 2025 5:51:11 UTC
HONG KONG, Feb. 24, 2025 /PRNewswire/ --Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 / VEGF bispecific antibody, in combination with several of Pfizer's antibody drug conjugates (ADCs) across multiple solid tumor settings.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities